Preclinical CRO Services

The NDT teams in specialized in both non-GLP and GLP compliant pre-clinical assessments of CNS disease therapeutics using a variety of biomarkers, including histology, immunohistochemical and histochemical methods. In particular, NDT is dedicated to custom-designed neuropathological assessments for the neurodegenerative diseases, such as Alzheimer`s, Parkinson`s, ALS, and brain insults (strokes and brain tumors) and Human neural stem cell and small molecule biomarker programs for preclinical studies of animal models upon request. NDT helps our clients develop the most time- and cost-effective study design and analytical methods with digital imaging platform with unbiased, computerized morphological analysis to render most reliable scientific results.